Overview

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up

Status:
Unknown status
Trial end date:
2020-12-01
Target enrollment:
0
Participant gender:
All
Summary
This study compares the efficacy and effectiveness of two of the second-generation antipsychotics (SGAs) most used in our society in the treatment of schizophrenia (Aripiprazole and Risperidone) and the investigators do within an assistance program of early-stage psychosis individuals of the Community of Cantabria, clinical reference for the treatment of this disease in the Spanish Autonomous Community. Patients are included in a prospective naturalistic study, open flexible-doses and randomized into one of two possible patterns of treatment that includes the protocol.
Phase:
Phase 4
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Fundación Marques de Valdecilla
Collaborators:
Centro de Investigación Biomédica en Red de Salud Mental
Instituto de Investigación Marqués de Valdecilla
Treatments:
Antipsychotic Agents
Aripiprazole
Risperidone
Criteria
Inclusion Criteria:

- Experiencing their first episode of psychosis (First Episode of Psychosis is defined
as that psychopathological state in which for the first time and regardless of its
duration, the patient has enough severe psychotic symptoms to allow a diagnosis of
psychosis, having received no specific psychiatric treatment for him).

- Living in the catchment area (Cantabria).

- No prior treatment with antipsychotic medication or, if previously treated, a total
life time of adequate antipsychotic treatment of less than 6 weeks.

- Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV)
criteria for brief psychotic disorder, schizophreniform disorder, schizophrenia, or
schizoaffective disorder.

Exclusion Criteria:

- Meeting DSM-IV criteria for drug dependence.

- Meeting DSM-IV criteria for mental retardation.

- Having a history of neurological disease or head injury with loss of consciousness.